A new approach towards highly sensitive detection of endogenous N-acetylaspartic acid, N-acetylglutamic acid, and N-acetylaspartylglutamic acid in brain tissues based on strong anion exchange monolith microextraction coupled with UHPLC-MS/MS

• Published in: Mikrochimica acta (1966) 2024-06, Vol.191 (6), p.360, Article 360
• Main Authors: Zhou, Wenxiu, Lv, Xiaoyuan, Zhang, Shengman, Gao, Zhenye, Li, Bingjie, Wang, Xin
• Format: Article
• Language: English
• Subjects: Acids; Analytical Chemistry; Animals; Anion exchanging; Aspartic Acid - analogs & derivatives; Aspartic Acid - analysis; Biomarkers; Biomarkers - analysis; Brain; Brain - metabolism; Brain Chemistry; Cerebellum; Cerebral cortex; Characterization and Evaluation of Materials; Chemistry; Chemistry and Materials Science; Chromatography, High Pressure Liquid - methods; Dipeptides - analysis; Functional groups; Glutamates; High performance liquid chromatography; Limit of Detection; Male; Mass spectrometry; Mice; Microengineering; Nanochemistry; Nanotechnology; Original Paper; Solid Phase Microextraction - methods; Solid phases; Tandem Mass Spectrometry - methods
• ISSN: 0026-3672; 1436-5073; 1436-5073
• DOI: 10.1007/s00604-024-06431-z

A novel in-tube solid-phase microextraction coupled with an ultra-high performance liquid chromatography-mass spectrometry method has been established for simultaneous quantification of three crucial brain biomarkers N -acetylaspartic acid (NAA), N -acetylglutamic acid (NAG), and N -acetylaspartylglutamic acid (NAAG). A polymer monolith with quaternary ammonium as the functional group was designed and exhibited efficient enrichment of target analytes through strong anion exchange interaction. Under the optimized conditions, the proposed method displayed wide linear ranges (0.1–80 nM for NAA and NAG, 0.2–160 nM for NAAG) with good precision (RSDs were lower than 15%) and low limits of detection (0.019–0.052 nM), which is by far the most sensitive approach for NAA, NAG, and NAAG determination. Furthermore, this approach has been applied to measure the target analytes in mouse brain samples, and endogenous NAA, NAG, and NAAG were successfully detected and quantified from only around 5 mg of cerebral cortex, cerebellum, and hippocampus. Compared with existing methods, the newly developed method in the current study provides highest sensitivity and lowest sample consumption for NAA, NAG, and NAAG measurements, which would potentially be utilized in determining and tracking these meaningful brain biomarkers in diseases or treatment processes, benefiting the investigations of pathophysiology and treatment of brain disorders. Graphical abstract